Showing results (1-10 of 262) with videos related to
Sort By:
Pageof 27
Psychopharmacology|November 15, 1997
SSRI treatment decreases prolactin and hyperthermic responses to mCPPD J Quested, P A Sargent, P J CowenPsychopharmacology|December 23, 1998
Clomipramine enhances the cortisol response to 5-HTP: implications for the therapeutic role of 5-HT2 receptorsP A Sargent, D J Quested, P J CowenJournal of Psychopharmacology (Oxford, England)|January 1, 1997
Changes in plasma prolactin during SSRI treatment: evidence for a delayed increase in 5-HT neurotransmissionP J Cowen, P A SargentThe British Journal of Psychiatry : the Journal of Mental Science|April 16, 1998
Brain 5-HT neurotransmission during paroxetine treatmentP A Sargent, D J Williamson, P J CowenPsychopharmacology|June 27, 2000
Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramineR Whale, D J Quested, D Laver, et al.Psychopharmacology|November 15, 1997
5-HT2C receptor activation decreases appetite and body weight in obese subjectsP A Sargent, A L Sharpley, C Williams, et al.Molecular Psychiatry|March 26, 2004
Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635Z Bhagwagar, E A Rabiner, P A Sargent, et al.Psychopharmacology|October 1, 1995
Melatonin phase advances circadian rhythmM E Attenburrow, B A Dowling, P A Sargent, et al.Acta Psychiatrica Scandinavica|June 15, 2017
Melatonin as a treatment for mood disorders: a systematic reviewF De Crescenzo, A Lennox, J C Gibson, et al.Medical Hypotheses|March 1, 1996
If Schizophrenia is enantiomorphism, is light the morphogen?D J QuestedPageof 27